- Home
- » Tags
- » Humanized antibody
Top View
- Antibody–Drug Conjugates for Cancer Therapy
- CD20-TCB with Obinutuzumab Pretreatment As Next Generation Treatment of Hematological Malignancies
- INN Working Document 05.179 Update 2011
- Original Article Two Engineered Site-Specific Antibody-Drug Conjugates, Hlmd4 and Hlvm4, Have Potent Therapeutic Activity in Two DLL4-Positive Tumour Xenograft Models
- Company Update
- Previous Monoclonal Antibodies Policy
- 14-350 Phrma Cancer2014 1001.Indd
- IUPAC Glossary of Terms Used in Immunotoxicology (IUPAC Recommendations 2012)*
- Humanized Antibodies for Antiviral Therapy (Herpes Simplex Virus/Computer Modeling) MAN SUNG Co*T, MARGUERITE DESCHAMPS*, RICHARD J
- (INN) for Biological and Biotechnological Substances
- Augmentation of Nab-Paclitaxel Chemotherapy Response By
- Cancer Imaging with Radiolabeled Antibodies
- Unexpected Cross-Reactivity of Anti-Cathepsin B Antibodies Leads To
- Antibody Drug Nomenclature: -Umab -Zumab -Ximab
- WO 2017/011544 Al 19 January 2017 (19.01.2017) P O PCT
- Development of Therapeutic Antibody Technology and Recent
- Phase II Study of Alemtuzumab (CAMPATH-1) in Patients with HTLV-1–Associated Adult T-Cell Leukemia/Lymphoma Kamal Sharma1, John E
- Introduction to Diagnostic and Therapeutic Monoclonal Antibodies
- International Nonproprietary Names (INN) for Biological and Biotechnological Substances
- Development of Therapeutic Antibodies for the Treatment Of
- First-In-Human, Phase 1 Dose-Escalation Study of Biparatopic Anti-HER2 Antibody-Drug Conjugate MEDI4276 in Patients with HER2+ Advanced Breast Or Gastric Cancer
- Antibody Engineering and Therapeutics, the Annual Meeting Of
- Title: a Phase 1B/2 Study of Ramucirumab in Combination with LY2875358 in Patients with Advanced Cancer
- Biotech Drugs: Biological Therapeutic Agents
- Antibody-Drug Conjugates Used in Breast Cancers
- Ep 2371389 A2
- The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
- WO 2017/176965 Al 12 October 2017 (12.10.2017) P O P C T
- Company Update
- Antibody Nomenclature
- Antibody News You Should Know July 1 - 15, 2020
- (Obinutuzumab), Humanized Antibody
- Radiomarquage Au 99Mtc Des Iga Et Igg : Optimisation Du Marquage, Étude in Vitro, Biodistribution Chez L’Animal Sain Et Sur Modèle Tumoral Hélène Carpenet Guéry
- Advances in Targeted Therapy for Esophageal Cancer
- (INN) for Biological and Biotechnological Substances
- A Review of Anti-Angiogenic Targets for Monoclonal Antibody Cancer Therapy
- Recent Advances in Monoclonal Antibody Therapy for Colorectal Cancers
- Chapter 2 Molecular Imaging to Enlighten Cancer Immunotherapies and Underlying Involved Processes
- WO 2015/036956 Al 19 March 2015 (19.03.2015) P O P C T
- Company Update November 20, 2014
- Cmet Axis in Cancer Therapy
- Antibody Therapies in Cancer